BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19298760)

  • 1. Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats.
    Tang J; Li YJ; Mu J; Li Q; Yang DY; Xie P
    Neurol Res; 2009 Mar; 31(2):189-94. PubMed ID: 19298760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorrhagic profile of the fibrinolytic alfimeprase after ischemia and reperfusion.
    Lu A; Kurosawa Y; Luskey K; Pyne-Geithman G; Caudell D; Clark J
    Neurol Res; 2009 Mar; 31(2):209-14. PubMed ID: 19298764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats.
    Turner RJ; Vink R
    Neuroscience; 2012 Sep; 220():1-10. PubMed ID: 22750240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermia masks the neuroprotective effects of tissue plaminogen activator.
    Noor R; Wang CX; Shuaib A
    Stroke; 2005 Mar; 36(3):665-9. PubMed ID: 15705940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia.
    Li M; Zhang Z; Sun W; Koehler RC; Huang J
    Neurobiol Dis; 2011 Dec; 44(3):277-83. PubMed ID: 21816222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.
    Qin Z; Karabiyikoglu M; Hua Y; Silbergleit R; He Y; Keep RF; Xi G
    Stroke; 2007 Apr; 38(4):1362-7. PubMed ID: 17322079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very Mild Hypothermia (35°C) Postischemia Reduces Infarct Volume and Blood/Brain Barrier Breakdown Following tPA Treatment in the Mouse.
    Cechmanek BK; Tuor UI; Rushforth D; Barber PA
    Ther Hypothermia Temp Manag; 2015 Dec; 5(4):203-8. PubMed ID: 26075540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Liu KJ
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT; Zhao JG; Li MH; Li YD
    Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
    Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
    Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
    Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
    Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.